Clarot Timothy

Avg. Two Year Performance

No purchase track record

14% Avg. Sale Return

7% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	18%	51%	76%	74%	14%
Sale Success Rate	3 of 3	3 of 3	3 of 3	3 of 3	1 of 3

Matrixx Initiatives Inc.

Drugs » Drug Delivery

VP Research and Development:

Holdings: 0 shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--